KLRS
Kalaris Therapeutics
KLRS
KLRS
90 hedge funds and large institutions have $115M invested in Kalaris Therapeutics in 2023 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 40 increasing their positions, 20 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
37% less capital invested
Capital invested by funds: $184M → $115M (-$68.1M)
42% less call options, than puts
Call options by funds: $59K | Put options by funds: $102K
Holders
90
Holding in Top 10
–
Calls
$59K
Puts
$102K
Top Buyers
| 1 | +$1.14M | |
| 2 | +$1.12M | |
| 3 | +$728K | |
| 4 |
Morgan Stanley
New York
|
+$605K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$550K |
Top Sellers
| 1 | -$2.5M | |
| 2 | -$1.36M | |
| 3 | -$1.27M | |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$1.04M |
| 5 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$994K |